Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
Christian DehlendorffLouise BaandrupSusanne K KjaerPublished in: Journal of the National Cancer Institute (2022)
HPV vaccination before 17 years of age reduces the risk of vulvar and vaginal HSIL+ based on real-world data.